Health System

The approval makes zanubrutinib available to all patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whether they are newly diagnosed or previously treated.

A group of pharmacists rose to the occasion to help a man having a medical emergency aboard a recent United flight bound for Newark, New Jersey.

The U.S. biosimilar landscape is changing, and legislation may be the key to controlling drug prices and advancing the market.

Cost savings were not associated with an increase in adverse drug events.

Knowledge gaps can make OTC medication recommendations for this population a challenge.

Low-income subsidies can eliminate much of the out-of-pocket costs that patients must pay.

Direct-to-consumer companies attract attention on social media, but are they as effective as traditional healthcare services?

Not every pharmacist may feel comfortable administering vaccines to children, but education could help.

Pharmacists can optimize medication adherence and serve as an additional touchpoint for patients during treatment.

Two clinical pathways were created to manage patients and required resources.

Diabetes self-management education and diabetes prevention programs can improve patient outcomes including mental health and HbA1C.

Biosimilars have the potential to create immense savings.

Developing more advanced roles for pharmacy technician can reduce turnover in roles.

Faced with access problems, women could be positively impacted by pharmacists having prescribing powers in New York state.

Providing culturally competent care is one way pharmacists can help improve vaccine uptake in their communities.

Immunocompromised adults aged 19 years or older are eligible to receive the recombinant zoster vaccine.

Take a look back at our most popular health system coverage for 2022.

As the main course of treatment for cancer-related pain, the use of opioids comes with a number of issues for both patients and prescribers.

Timing of treatment initiation is crucial for patients with cancer.

Collecting data on social determinants of health carries a number of issues and needs to be improved to create learning health systems.

While the use of chemotherapy at end of life is decreasing, the use of immunotherapy is increasing.

Follow-ups from pharmacists show a significant increase in outpatient antiemetic drugs prescribed and quality of life in patients experiencing chemotherapy-induced nausea and vomiting.

Tackling Medicare Part D drug costs takes more than just capping costs.

Childhood cancer survivors are high risk of pain and in need of pain relief. Did 2016 guidelines for opioid prescribing change use in this group?

Cancer care is expensive, but pharmacists can help.

This is the first approved therapy targeted to patients with the HER2-low breast cancer subtype. Its approval comes four months ahead of its PDUFA action date.

The specialty drug pipeline includes first- and next-in- class drugs across the oncology and immunology spaces.

Monoclonal antibodies have been helpful in preventing severe illness in patients at increased risk, but barriers to receiving this therapy exist.

Comprehensive medication management has been shown to improve disease markers, and new research indicates it could also reduce costs.